$ENTB Entest BioMedical Inc. is the parent company of Zander Therapeutics Inc. The focus of Zander Therapeutics, Inc. is to develop small molecule immunotherapies and cancer stem cell therapies for the veterinary market.
$ENTB is specifically focused on animal therapies that address unmet medical needs. Zander is looking to increase the quality of life in animals through therapies involving small molecules, stem cell treatments and the body’s own immune system.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.